Pharmacogenomic Research in Korean Patients With Hepatitis C

Pharmacogenomic Research for Prediction of Drug Response in Korean Patients With Hepatitis C

The aim of this study is to investigate the relationships between drug response and the host genetic factors, viral factors and clinical factors in chronic hepatitis C patients (HCV). And thus, the investigators are trying to develop the pharmacogenomic guideline in the Korean patients with HCV.

Inclusion Criteria:

• Hepatitis C virus infected patients

Exclusion Criteria:

• Patients who infected Hepatitis B virus or Human immunodeficiency virus
• HCV infected patients previously treated with antiviral drugs
• Patients had a history of autoimmune hemolytic anemia